Virus (RSV) Infections C Pipeline Review, H2 2014 Companies Involved in Therapeutics Development: F.
Analysis of respiratory syncytial
virus strain variation in successive epidemics in one city.
Okairos is a clinical-stage biopharmaceutical company, developing genetic vaccines for major infectious diseases - including malaria, hepatitis C, HIV, respiratory syncytial
virus and cancer - using a novel proprietary technology.
An update on respiratory syncytial
virus epidemiology: a developed country perspective.
Occurrence and severity of infections caused by subgroup A and B respitatory syncytial
virus in children in southeast Brasil.
virus (RSV) infection is an important but rarely lethal respiratory tract disease in infants and young children.
Ventricular arrhythmia associated with respiratory syncytial
VIRUS (RSV) has been implicated in nearly 75% of bronchiolitis cases and in more than 50% of pneumonia cases.
Of 2,226 swab samples, 480 were identified as respiratory syncytial
virus (RSV) and 709 were identified as influenza.
The Wyeth-Lederle respiratory syncytial
virus (RSV) purified fusion protein-2 vaccine was safe and immunogenic in women who received it at 30-34 weeks' gestation in an exploratory 35-subject, randomized, placebo-controlled, double-blind trial.
Pathologic Diagnosis: Syncytial
Variant of Nodular Sclerosing Hodgkin Disease
RSV stands for respiratory syncytial
virus, an influenza-like virus and the single most important cause of lower respiratory tract infection in infants and children.